Thermal Conditioning and Vasomotor Training
Certainty: 0.30. If ME/CFS involves tonic vasoconstriction bias compressing vasomotor dynamic range (ch10:Tonic Cutaneous Vasoconstriction Bias Explains Dual Heat+Cold Intolerance), contrast hydrotherapy — alternating warm (38–40°C) and cool (15–20°C) water immersion — operates through three complementary mechanisms. Vasomotor training: repeated dilation-constriction cycles expand the functional range of cutaneous perfusion, analogous to vascular interval training. UPR hormesis: heat pulses induce mild ER stress with HSP70 upregulation, building ER stress tolerance through the same hormetic principle documented in Hochecker 2025 (hyperthermia → mitochondrial improvement) (Hochecker et al. 2025). For the broader hormetic dose-response framework as a systems principle, see Chapter Integrative Models and Multi-System Pathophysiology — the inverted-U dose-response pattern observed across multiple ME/CFS pharmacotherapies (LDN, LDA, lithium, melatonin) may reflect the same adaptive-reserve recruitment principle operative here through thermal rather than pharmacological stress. SPM induction: the heat→cold transition may stimulate resolvin and protectin production via TRPV1/TRPA1 activation on sensory nerves, enhancing inflammation resolution. Important parsimony caveat: these three “mechanisms” may describe the same physiological event — heat-induced vasodilation — from three disciplinary angles (vascular, cellular-stress, immunological) rather than representing dissociable, independent targets. The SPM induction arm via TRPV1/TRPA1 has not been demonstrated in vivo in any human condition; the Hochecker evidence supports passive whole-body hyperthermia at 39°C, not alternating immersion. A graduated protocol starting at mild gradients (30°C/25°C) and progressing to moderate (38°C/15°C) over 12 weeks minimises risk of orthostatic intolerance while building vasomotor reserve, UPR competence, and resolution capacity. Structured: hot 15 min → cool 1–2 min × 3 rounds, 3×/week. Falsifiable: contrast hydrotherapy vs thermoneutral control over 12 weeks increases cutaneous perfusion range (warm-cold difference by laser Doppler) by >30% AND PBMC HSP70 by ≥20% (co-primary endpoints anchored to core mechanisms: vasomotor training and UPR hormesis). Falsified if neither co-primary endpoint is met. Secondary endpoints (FGF21, IL-6, SF-36 PF) provide supportive evidence but do not independently falsify.
Certainty: 0.35. Hochecker et al. demonstrated that acute WBH (39°C) improves PBMC mitochondrial respiration (Hochecker et al. 2025) — but several patients could not tolerate the full protocol. A paced approach mirroring exercise pacing principles may enable thermotolerance adaptation: start at 32°C water immersion (10 min, 2x/week), step up 2°C every 2 weeks to a ceiling of 38°C, with strict PEM monitoring. This gradual protocol recruits HSP70 incrementally without the overload risk of acute WBH. Falsifiable: paced heat exposure vs flat-temperature control over 12 weeks increases heat tolerance time by >100% and HSP70 by >2-fold with PEM rate below 10%. No ME/CFS dose-response data; the Hochecker protocol was single-session acute exposure.
Certainty: 0.25. If Waon therapy (far-infrared sauna, 60°C ambient) produces clinical benefit via the HSP70 → autophagy normalization → mitochondrial improvement pathway (ch06:Spare Respiratory Capacity as Thermoregulatory Capacity Proxy in ME/CFS), and the effective stimulus is core temperature elevation sufficient to activate HSF1, then hot water immersion may be mechanistically equivalent — water transfers heat far more efficiently than infrared air, potentially reaching the same HSP70 induction threshold at a lower ambient temperature and shorter duration. The existing paced heat exposure protocol (ch17:Paced Heat Exposure: Temperature Step-Up Protocol for Thermotolerance Building) already uses water immersion as the delivery method; this speculation explicitly extends the Waon mechanism to home-accessible hot baths (38–40°C, 10–15 min, supine position, shower chair). Falsifiable: a hot bath protocol (40°C, 15 min, 3x/week, 8 weeks) produces PBMC HSP70 induction and mitochondrial respiratory improvement of equivalent magnitude to Waon therapy (within 20% non-inferiority margin). No head-to-head hot bath vs Waon data exist; HSF1 activation threshold for HSP70 induction in ME/CFS immune cells is unknown; heat-intolerant and POTS-comorbid patients are excluded.